[1]
Valenzuela, R. et al. 2025. Pilot Study on Evaluating Multiparametric MRI (mp-MRI) Including Contrast-Enhanced Susceptibility Imaging (CE-SWI) in Predicting Pathology Treatment Response in Rhabdomyosarcoma. Journal of Radiology and Oncology. 9, 3 (Nov. 2025), 062–074. DOI:https://doi.org/10.29328/journal.jro.1001083.